Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 1
1988 2
1989 1
1990 1
1991 4
1992 1
1993 3
1994 5
1995 4
1996 4
1997 1
1998 3
1999 2
2000 2
2001 6
2002 5
2003 3
2004 10
2005 9
2006 11
2007 12
2008 19
2009 13
2010 18
2011 20
2012 14
2013 17
2014 16
2015 16
2016 17
2017 13
2018 17
2019 15
2020 18
2021 20
2022 17
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Results by year

Filters applied: . Clear all
Page 1
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, Babovic-Vuksanovic D, Ferner R, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Hanemann CO, Kalamarides M, Kehrer-Sawatzki H, Korf BR, Mautner VF, MacCollin M, Papi L, Rauen KA, Riccardi V, Schorry E, Smith MJ, Stemmer-Rachamimov A, Stevenson DA, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Wolkenstein P, Evans DG. Plotkin SR, et al. Genet Med. 2022 Sep;24(9):1967-1977. doi: 10.1016/j.gim.2022.05.007. Epub 2022 Jun 9. Genet Med. 2022. PMID: 35674741 Free article.
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.
Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, Blakeley J, Babovic-Vuksanovic D, Cunha KS, Ferner R, Fisher MJ, Friedman JM, Gutmann DH, Kehrer-Sawatzki H, Korf BR, Mautner VF, Peltonen S, Rauen KA, Riccardi V, Schorry E, Stemmer-Rachamimov A, Stevenson DA, Tadini G, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Evans DG, Plotkin SR. Legius E, et al. Genet Med. 2021 Aug;23(8):1506-1513. doi: 10.1038/s41436-021-01170-5. Epub 2021 May 19. Genet Med. 2021. PMID: 34012067 Free PMC article.
Bier's spots.
Kluger N, Bessis D. Kluger N, et al. Among authors: bessis d. J Eur Acad Dermatol Venereol. 2019 Feb;33(2):e78-e79. doi: 10.1111/jdv.15222. Epub 2018 Sep 19. J Eur Acad Dermatol Venereol. 2019. PMID: 30160813 No abstract available.
Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
Maruani A, Tavernier E, Boccara O, Mazereeuw-Hautier J, Leducq S, Bessis D, Guibaud L, Vabres P, Carmignac V, Mallet S, Barbarot S, Chiaverini C, Droitcourt C, Bursztejn AC, Lengellé C, Woillard JB, Herbreteau D, Le Touze A, Joly A, Léauté-Labrèze C, Powell J, Bourgoin H, Gissot V, Giraudeau B, Morel B. Maruani A, et al. Among authors: bessis d. JAMA Dermatol. 2021 Nov 1;157(11):1289-1298. doi: 10.1001/jamadermatol.2021.3459. JAMA Dermatol. 2021. PMID: 34524406 Free PMC article. Clinical Trial.
High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
Bubien V, Bonnet F, Brouste V, Hoppe S, Barouk-Simonet E, David A, Edery P, Bottani A, Layet V, Caron O, Gilbert-Dussardier B, Delnatte C, Dugast C, Fricker JP, Bonneau D, Sevenet N, Longy M, Caux F; French Cowden Disease Network. Bubien V, et al. J Med Genet. 2013 Apr;50(4):255-63. doi: 10.1136/jmedgenet-2012-101339. Epub 2013 Jan 18. J Med Genet. 2013. PMID: 23335809 Free article.
Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature.
Demortier J, Vautier M, Chosidow O, Gallay L, Bessis D, Berezne A, Cordel N, Schmidt J, Smail A, Duffau P, Jachiet M, Begon E, Gottlieb J, Chasset F, Graveleau J, Marque M, Cesbron E, Forestier A, Josse S, Kluger N, Beauchêne C, Le Corre Y, Pagis V, Rigolet A, Guillaume-Jugnot P, Authier FJ, Guilain N, Streichenberger N, Leonard-Louis S, Boussouar S, Landon-Cardinal O, Benveniste O, Allenbach Y. Demortier J, et al. Among authors: bessis d. Rheumatology (Oxford). 2023 Dec 1;62(12):3932-3939. doi: 10.1093/rheumatology/kead154. Rheumatology (Oxford). 2023. PMID: 37010495 Review.
PELVIS Syndrome.
Girard C, Bigorre M, Guillot B, Bessis D. Girard C, et al. Among authors: bessis d. Arch Dermatol. 2006 Jul;142(7):884-8. doi: 10.1001/archderm.142.7.884. Arch Dermatol. 2006. PMID: 16847205 Review.
[Type I interferonopathies].
Munoz J, Marque M, Dandurand M, Meunier L, Crow YJ, Bessis D. Munoz J, et al. Among authors: bessis d. Ann Dermatol Venereol. 2015 Nov;142(11):653-63. doi: 10.1016/j.annder.2015.06.018. Epub 2015 Sep 9. Ann Dermatol Venereol. 2015. PMID: 26363997 French.
[Neuro-cardio-facial-cutaneous syndrome].
Bessis D. Bessis D. Ann Dermatol Venereol. 2011 Jun-Jul;138(6-7):483-93. doi: 10.1016/j.annder.2011.02.029. Epub 2011 May 5. Ann Dermatol Venereol. 2011. PMID: 21700069 French.
Multiple Postvaccinal Pilomatrixomas in a Child.
Raison-Peyron N, Secco LP, Delfour C, Captier G, Bessis D. Raison-Peyron N, et al. Among authors: bessis d. Clin Pediatr (Phila). 2023 Jul;62(7):692-694. doi: 10.1177/00099228221144941. Epub 2022 Dec 15. Clin Pediatr (Phila). 2023. PMID: 37293757 No abstract available.
307 results